Menu

Markets

Research

News

Learn

AI Chat
Get the app WatchlistsPortfoliosAlerts
Sign in

Estrella Immunopharma, Inc. ESLAW

Full chart Compare
Set alert

Price alert · ESLAW

All alert types
0.08 USD 0.00 (+0.00%)

Nov 2, 2026, 10:56 AM EST

0.0799 Day range 0.08
0.0799 52-week range 0.08
YTD
0.00%
1 year
0.00%

Financial health

Altman Z-Score

-53.07 Distress zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

2 / 9 Weak

Nine pass/fail tests of profitability, leverage and efficiency.

Valuation

P/E -4.5×
FY 2020: -469×FY 2021: -207×FY 2022: -32.2×FY 2023: -5.2×FY 2024: -5.0×FY 2025: -4.5×
FY 2020 5y median -5.2× FY 2025
P/S 0.0×
FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 0.0×
FY 2020 5y median 0.0× FY 2025
P/B -5.5×
FY 2020: 0.0×FY 2021: -335×FY 2022: 51.2×FY 2023: 9.1×FY 2024: 306×FY 2025: -5.5×
FY 2020 5y median 9.1× FY 2025
P/FCF -32.2×
FY 2020: -512×FY 2021: -242×FY 2022: -347×FY 2023: -2.4×FY 2024: -14.1×FY 2025: -32.2×
FY 2020 5y median -32.2× FY 2025
EV/EBITDA -4.3×
FY 2020: 0.0×FY 2021: -205×FY 2022: -32.6×FY 2023: -4.7×FY 2024: -4.9×FY 2025: -4.3×
FY 2020 5y median -4.9× FY 2025
EV/Sales 0.0×
FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 0.0×
FY 2020 5y median 0.0× FY 2025
FCF Yield -3.1%
FY 2020: -0.2%FY 2021: -0.4%FY 2022: -0.3%FY 2023: -41.5%FY 2024: -7.1%FY 2025: -3.1%
FY 2020 5y median -3.1% FY 2025

Profitability

Gross Margin 0.0%
FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2020 5y median 0.0% FY 2025
Operating Margin 0.0%
FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2020 5y median 0.0% FY 2025
Net Margin 0.0%
FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2020 5y median 0.0% FY 2025
ROE 126.0%
FY 2020: 0.0%FY 2021: 162.1%FY 2022: -157.2%FY 2023: -171.1%FY 2024: -6155.7%FY 2025: 126.0%
FY 2020 5y median -157.2% FY 2025
ROIC 126.0%
FY 2020: 0.0%FY 2021: -3.4%FY 2022: -118.1%FY 2023: -51.5%FY 2024: -6154.5%FY 2025: 126.0%
FY 2020 5y median -51.5% FY 2025
ROA -411.2%
FY 2020: 0.0%FY 2021: -34.2%FY 2022: -111.3%FY 2023: -164.2%FY 2024: -281.7%FY 2025: -411.2%
FY 2020 5y median -164.2% FY 2025

Growth (YoY)

Revenue 0.0%
FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2020 FY 2025
Operating Income -47.7%
FY 2020: 0.0%FY 2021: -129.7%FY 2022: -559.5%FY 2023: 34.2%FY 2024: -21.0%FY 2025: -47.7%
FY 2020 FY 2025
EPS (diluted) -45.8%
FY 2020: 0.0%FY 2021: -130.3%FY 2022: -568.1%FY 2023: 34.4%FY 2024: -14.3%FY 2025: -45.8%
FY 2020 FY 2025
Free Cash Flow 42.6%
FY 2020: 0.0%FY 2021: -115.0%FY 2022: 27.6%FY 2023: -1439.3%FY 2024: 80.6%FY 2025: 42.6%
FY 2020 FY 2025

Financial Health

Current Ratio 0.1×
FY 2020: 0.0×FY 2021: 5.2×FY 2022: 0.0×FY 2023: 24.6×FY 2024: 0.5×FY 2025: 0.1×
FY 2020 5y median 0.5× FY 2025
Quick Ratio 0.1×
FY 2020: 0.0×FY 2021: 5.2×FY 2022: 0.0×FY 2023: 24.6×FY 2024: 0.5×FY 2025: 0.1×
FY 2020 5y median 0.5× FY 2025
Debt / Equity 0.0×
FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.1×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 0.0×
FY 2020 5y median 0.0× FY 2025
Net Debt / EBITDA 0.1×
FY 2020: 0.0×FY 2021: 2.4×FY 2022: -0.0×FY 2023: 0.6×FY 2024: 0.1×FY 2025: 0.1×
FY 2020 5y median 0.1× FY 2025
Interest Coverage 0.0×
FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 0.0×
FY 2020 5y median 0.0× FY 2025

Dividends

Dividend Yield 0.0%
FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2020 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2020 5y median 0.0% FY 2025

Annual · latest fiscal year ends 2025-12-31